AAPL329.74-3.28 (-0.98%) ▼|ABBV260.24-1.35 (-0.52%) ▼|ABT97.47-1.37 (-1.38%) ▼|ACN216.39+33.02 (+18.00%) ▲|ADBE241.59+1.65 (+0.69%) ▲|AMAT529.73+18.35 (+3.59%) ▲|AMD616.71+4.95 (+0.81%) ▲|AMGN410.16-11.35 (-2.69%) ▼|AMT161.43-2.27 (-1.38%) ▼|AMZN249.21+0.06 (+0.02%) ▲|AVGO348.91-2.29 (-0.65%) ▼|AXP300.50-3.60 (-1.18%) ▼|BA189.54+3.49 (+1.87%) ▲|BAC53.73-0.71 (-1.30%) ▼|BKNG161.10-1.81 (-1.11%) ▼|BLK1,070.35+12.06 (+1.14%) ▲|BMY61.52-0.88 (-1.41%) ▼|BNY143.51-1.12 (-0.77%) ▼|BRK-B498.93+0.98 (+0.20%) ▲|C127.22-2.26 (-1.75%) ▼|CAT826.28+15.49 (+1.91%) ▲|CL84.53-0.80 (-0.93%) ▼|CMCSA21.75-0.02 (-0.07%) ▼|COF193.10+0.03 (+0.02%) ▲|COP126.61+1.46 (+1.17%) ▲|COST916.99+6.65 (+0.73%) ▲|CRM234.66+5.09 (+2.22%) ▲|CSCO108.45+0.82 (+0.76%) ▲|CVS85.52-0.17 (-0.20%) ▼|CVX206.49+2.28 (+1.12%) ▲|DE662.60-8.95 (-1.33%) ▼|DHR213.26-8.29 (-3.74%) ▼|DIS101.55-3.35 (-3.19%) ▼|DUK113.64-0.38 (-0.33%) ▼|EMR157.67+2.57 (+1.66%) ▲|FDX286.99+1.90 (+0.66%) ▲|GD333.06+1.23 (+0.37%) ▲|GE312.56+0.27 (+0.08%) ▲|GEV990.35+39.86 (+4.19%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM78.10+1.10 (+1.43%) ▲|GOOG336.08-4.67 (-1.37%) ▼|GOOGL339.32-4.76 (-1.38%) ▼|GS896.34-4.02 (-0.45%) ▼|HD281.58-2.91 (-1.02%) ▼|HON213.64+2.70 (+1.28%) ▲|IBM227.97+8.04 (+3.66%) ▲|INTC121.35+1.12 (+0.93%) ▲|INTU283.23+7.52 (+2.73%) ▲|ISRG401.47-5.17 (-1.27%) ▼|JNJ258.61-6.14 (-2.32%) ▼|JPM332.51+1.68 (+0.51%) ▲|KO85.80-0.29 (-0.33%) ▼|LIN468.57-6.08 (-1.28%) ▼|LLY1,140.46-16.63 (-1.44%) ▼|LMT506.45-2.80 (-0.55%) ▼|LOW182.12-2.18 (-1.18%) ▼|LRCX337.28+8.77 (+2.67%) ▲|MA549.46-2.01 (-0.36%) ▼|MCD231.33+0.39 (+0.17%) ▲|MDLZ57.71-0.11 (-0.19%) ▼|MDT85.58-0.72 (-0.83%) ▼|META728.48+3.30 (+0.45%) ▲|MMM162.69-1.47 (-0.89%) ▼|MO66.84-0.51 (-0.75%) ▼|MRK143.53-1.78 (-1.23%) ▼|MS187.18-0.91 (-0.48%) ▼|MSFT515.47+2.57 (+0.50%) ▲|MU1,091.50+26.39 (+2.48%) ▲|NEE76.30+0.56 (+0.73%) ▲|NFLX68.33-1.25 (-1.80%) ▼|NKE35.93+0.53 (+1.50%) ▲|NOW137.73+3.72 (+2.77%) ▲|NVDA230.76+2.38 (+1.04%) ▲|ORCL138.81+1.51 (+1.10%) ▲|PEP125.81-0.91 (-0.72%) ▼|PFE28.18-0.34 (-1.20%) ▼|PG144.15-1.13 (-0.78%) ▼|PLTR189.53+2.48 (+1.32%) ▲|PM187.40-3.43 (-1.79%) ▼|QCOM185.01+0.97 (+0.53%) ▲|RTX184.90-0.75 (-0.40%) ▼|SBUX94.35+0.39 (+0.42%) ▲|SCHW98.05+0.31 (+0.31%) ▲|SO83.20+0.31 (+0.37%) ▲|SPG200.15-0.62 (-0.31%) ▼|T24.38-0.03 (-0.10%) ▼|TMO657.40-17.65 (-2.61%) ▼|TMUS161.98-1.10 (-0.67%) ▼|TSLA355.81+1.00 (+0.28%) ▲|TXN281.30+1.21 (+0.43%) ▲|UBER67.98-0.54 (-0.78%) ▼|UNH364.69-2.39 (-0.65%) ▼|UNP270.44-1.69 (-0.62%) ▼|UPS93.99+0.55 (+0.58%) ▲|USB56.77-1.00 (-1.72%) ▼|V358.96-0.37 (-0.10%) ▼|VZ46.01+0.14 (+0.29%) ▲|WFC79.51-0.54 (-0.67%) ▼|WMT104.87+0.95 (+0.91%) ▲|XOM163.83+1.08 (+0.66%) ▲|AAPL329.74-3.28 (-0.98%) ▼|ABBV260.24-1.35 (-0.52%) ▼|ABT97.47-1.37 (-1.38%) ▼|ACN216.39+33.02 (+18.00%) ▲|ADBE241.59+1.65 (+0.69%) ▲|AMAT529.73+18.35 (+3.59%) ▲|AMD616.71+4.95 (+0.81%) ▲|AMGN410.16-11.35 (-2.69%) ▼|AMT161.43-2.27 (-1.38%) ▼|AMZN249.21+0.06 (+0.02%) ▲|AVGO348.91-2.29 (-0.65%) ▼|AXP300.50-3.60 (-1.18%) ▼|BA189.54+3.49 (+1.87%) ▲|BAC53.73-0.71 (-1.30%) ▼|BKNG161.10-1.81 (-1.11%) ▼|BLK1,070.35+12.06 (+1.14%) ▲|BMY61.52-0.88 (-1.41%) ▼|BNY143.51-1.12 (-0.77%) ▼|BRK-B498.93+0.98 (+0.20%) ▲|C127.22-2.26 (-1.75%) ▼|CAT826.28+15.49 (+1.91%) ▲|CL84.53-0.80 (-0.93%) ▼|CMCSA21.75-0.02 (-0.07%) ▼|COF193.10+0.03 (+0.02%) ▲|COP126.61+1.46 (+1.17%) ▲|COST916.99+6.65 (+0.73%) ▲|CRM234.66+5.09 (+2.22%) ▲|CSCO108.45+0.82 (+0.76%) ▲|CVS85.52-0.17 (-0.20%) ▼|CVX206.49+2.28 (+1.12%) ▲|DE662.60-8.95 (-1.33%) ▼|DHR213.26-8.29 (-3.74%) ▼|DIS101.55-3.35 (-3.19%) ▼|DUK113.64-0.38 (-0.33%) ▼|EMR157.67+2.57 (+1.66%) ▲|FDX286.99+1.90 (+0.66%) ▲|GD333.06+1.23 (+0.37%) ▲|GE312.56+0.27 (+0.08%) ▲|GEV990.35+39.86 (+4.19%) ▲|GILD147.82-1.23 (-0.83%) ▼|GM78.10+1.10 (+1.43%) ▲|GOOG336.08-4.67 (-1.37%) ▼|GOOGL339.32-4.76 (-1.38%) ▼|GS896.34-4.02 (-0.45%) ▼|HD281.58-2.91 (-1.02%) ▼|HON213.64+2.70 (+1.28%) ▲|IBM227.97+8.04 (+3.66%) ▲|INTC121.35+1.12 (+0.93%) ▲|INTU283.23+7.52 (+2.73%) ▲|ISRG401.47-5.17 (-1.27%) ▼|JNJ258.61-6.14 (-2.32%) ▼|JPM332.51+1.68 (+0.51%) ▲|KO85.80-0.29 (-0.33%) ▼|LIN468.57-6.08 (-1.28%) ▼|LLY1,140.46-16.63 (-1.44%) ▼|LMT506.45-2.80 (-0.55%) ▼|LOW182.12-2.18 (-1.18%) ▼|LRCX337.28+8.77 (+2.67%) ▲|MA549.46-2.01 (-0.36%) ▼|MCD231.33+0.39 (+0.17%) ▲|MDLZ57.71-0.11 (-0.19%) ▼|MDT85.58-0.72 (-0.83%) ▼|META728.48+3.30 (+0.45%) ▲|MMM162.69-1.47 (-0.89%) ▼|MO66.84-0.51 (-0.75%) ▼|MRK143.53-1.78 (-1.23%) ▼|MS187.18-0.91 (-0.48%) ▼|MSFT515.47+2.57 (+0.50%) ▲|MU1,091.50+26.39 (+2.48%) ▲|NEE76.30+0.56 (+0.73%) ▲|NFLX68.33-1.25 (-1.80%) ▼|NKE35.93+0.53 (+1.50%) ▲|NOW137.73+3.72 (+2.77%) ▲|NVDA230.76+2.38 (+1.04%) ▲|ORCL138.81+1.51 (+1.10%) ▲|PEP125.81-0.91 (-0.72%) ▼|PFE28.18-0.34 (-1.20%) ▼|PG144.15-1.13 (-0.78%) ▼|PLTR189.53+2.48 (+1.32%) ▲|PM187.40-3.43 (-1.79%) ▼|QCOM185.01+0.97 (+0.53%) ▲|RTX184.90-0.75 (-0.40%) ▼|SBUX94.35+0.39 (+0.42%) ▲|SCHW98.05+0.31 (+0.31%) ▲|SO83.20+0.31 (+0.37%) ▲|SPG200.15-0.62 (-0.31%) ▼|T24.38-0.03 (-0.10%) ▼|TMO657.40-17.65 (-2.61%) ▼|TMUS161.98-1.10 (-0.67%) ▼|TSLA355.81+1.00 (+0.28%) ▲|TXN281.30+1.21 (+0.43%) ▲|UBER67.98-0.54 (-0.78%) ▼|UNH364.69-2.39 (-0.65%) ▼|UNP270.44-1.69 (-0.62%) ▼|UPS93.99+0.55 (+0.58%) ▲|USB56.77-1.00 (-1.72%) ▼|V358.96-0.37 (-0.10%) ▼|VZ46.01+0.14 (+0.29%) ▲|WFC79.51-0.54 (-0.67%) ▼|WMT104.87+0.95 (+0.91%) ▲|XOM163.83+1.08 (+0.66%) ▲|
25.6 C
New York
Thursday, October 1, 2026

globenewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Red Cat, Reckitt, UroGen and Fortrea and Encourages Investors...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Reckitt Benckiser Group plc (OTC:RBGLY), UroGen Pharma Ltd. (NASDAQ:URGN), Red Cat Holdings, Inc. (NASDAQ: RCAT) and Fortrea Holdings Inc. (NASDAQ:FTRE). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Krispy Kreme, Strategy Incorporated, Organon, and Iovance and Encourages...

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Krispy Kreme, Inc. (NASDAQ:DNUT), Strategy Incorporated (NASDAQ:MSTR), Organon & Co. (NYSE:OGN), and Iovance Biotherapeutics, Inc. (NASDAQ:IOVA). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against 3D Systems Corporation (DDD)

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the District of Delaware on behalf of all persons or entities who purchased or otherwise acquired 3D Systems Corporation (“3D Systems” or the “Company”) (NYSE: DDD) securities between August 13, 2024 and May 12, 2025, inclusive (the “Class Period”). The lawsuit seeks to recover damages for the Company’s investors under the federal securities laws.

Graphjet Technology Discloses Stay of Suspension and Nasdaq Hearing Date

Innovative technological leader to oversee all technical, operational, customer support and business development initiatives

Sizzle Acquisition Corp. II Completes $230,000,000 Initial Public Offering

NEW YORK, June 16, 2025 (GLOBE NEWSWIRE) -- Sizzle Acquisition Corp. II (the “Company”) announced today the completion of its initial public offering of 23,000,000 units at a price of $10.00 per unit, resulting in gross proceeds of $230,000,000.

Kyro CFO Launches Flexible Fractional CFO Services to Support Growing Businesses

Kyro CFO introduces flexible fractional CFO services to help growing businesses improve financial strategy, manage growth, and drive operational efficiency
Kyro CFO introduces flexible fractional CFO services to help growing businesses improve financial strategy, manage growth, and drive operational efficiency

NullTrace Announces Shadow DEX Rollout, AI Integrations & Upcoming Wallet Launch: Building Solana’s Full-Stack Privacy Layer

Dubai, UAE , June 16, 2025 (GLOBE NEWSWIRE) -- In a major leap toward redefining privacy in Web3, NullTrace officially announces the upcoming launch of its OTC marketplace (Phase 1 of Shadow DEX), AI dapp assistant & native privacy wallet, solidifying its position as the go-to privacy layer on Solana. As blockchain adoption grows and transparency becomes a double-edged sword, on-chain privacy is no longer optional—it’s critical infrastructure.

NullTrace offers a ZK-powered, full-stack privacy suite: stealth swaps, token mixers, private transfers and airdrops, and an untraceable cross-chain bridge. Its tools empower users with confidential custody, anonymous transfers, and unlinkable activity—all while maintaining decentralization and performance.

Privacy Without Compromise

Blockchain transparency has made wallet activity, trades, and airdrops fully public. This deters institutional adoption and exposes users to surveillance. NullTrace fixes this with stealth address infrastructure, encrypted balances, and zero-knowledge proofs—all native to Solana.

Key Offerings Include:

ZK Privacy Bridge: Enables unlinkable cross-chain value movement using stealth routing.

SPL Mixer: Native Solana mixer supporting SOL & SPL tokens, enabling encrypted transfers.

Privacy Airdrops: Distribute tokens to stealth addresses with zero exposure.

$NULL Token: Access tools, earn revshare, and participate in governance.

Protocol fees are shared with $NULL holders and partially burned, creating strong utility and alignment with growth.

What’s Coming Next

This announcement comes as NullTrace prepares to roll out two major privacy innovations:

Shadow DEX: A stealth orderbook DEX with encrypted matching and on-chain private settlement—ideal for OTC deals and DAO allocations.

Null Wallet: A fully integrated wallet optimized for stealth address management and shielded asset tracking.

AI Chat Assistant: Built into both web and Telegram interfaces, this guide helps users navigate complex privacy tools and protocols seamlessly.

Live Today

- SPL Mixer (SOL & tokens)

- Private Bridge (Solana-native)

- Stealth Airdrop Tool

- Revenue Sharing via $NULL

Coming in 2025

- Shadow DEX Phase 1

- Full AI Assistant Rollout

- Launch of Null Wallet

- EVM & Bitcoin Support

Final Word

NullTrace isn’t just building a mixer—it’s constructing the privacy foundation of Solana and Web3. With the upcoming launch of its privacy-native wallet and Shadow DEX, the protocol is delivering programmable, high-speed, trustless confidentiality to everyone—from retail users to DAOs and institutions.

Explore NullTrace:

Web App: https://nulltrace.xyz/

Docs: https://docs.nulltrace.xyz/

Twitter/X: https://x.com/nulltracebot

All Links: https://linktr.ee/nulltrace

Privacy isn’t a luxury. It’s infrastructure—and NullTrace is making it mainstream.

Disclaimer: The information provided in this press release is not a solicitation for investment, nor is it intended as investment advice, financial advice, or trading advice. It is strongly recommended you practice due diligence, including consultation with a professional financial advisor, before investing in or trading cryptocurrency and securities.

PolyPid Secures $26.7 Million Through Warrant Exercise Following Successful SHIELD II Phase 3 Trial Results

PETACH TIKVA, Israel, June 17, 2025 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) (“PolyPid” or the “Company”), a late-stage biopharma company aiming to improve surgical outcomes, today announced that following its recently announced successful SHIELD II phase 3 topline results, it has secured additional funding through the exercise of warrants with aggregate gross proceeds of $26.7 million. The Company anticipates that with this additional funding, PolyPid’s runway would be extended beyond anticipated FDA approval of D-PLEX₁₀₀.

Dr. Elad Yossefi and Dr. Tal Yossefi Introduce Tech-Enhanced Dental Services in Norwalk

Advanced Dental Center Expands Full-Mouth Restoration and Gum Disease Treatment with Modern Tools
Advanced Dental Center Expands Full-Mouth Restoration and Gum Disease Treatment with Modern Tools

Increase your potential income with Ripple (XRP) and Dogecoin (DOGE) through free cloud mining with BCC Mining

Ripple (XRP) and Dogecoin (DOGE) holders can enjoy free cloud mining through BCC Mining, increasing potential earnings
Ripple (XRP) and Dogecoin (DOGE) holders can enjoy free cloud mining through BCC Mining, increasing potential earnings

Meydan Free Zone تدعم الابتكار في مجال الامتثال عبر نموذج تأسيس رقمي سلس

أطلقت Meydan Free Zone نظامًا رقميًا بالكامل للامتثال، متوافقًا مع المعايير الإماراتية والعالمية، ويقدم موافقات سريعة، وتتبعًا لحظيًا، وتقييمًا قائمًا على المخاطر، بما يساعد رواد الأعمال على الحفاظ على جاهزيتهم للتدقيق، والامتثال للمتطلبات التنظيمية، والتطور بكفاءة في واحدة من أكثر بيئات الأعمال خضوعًا للرقابة في العالم.

Enzo Biochem Reports Third Quarter Fiscal Year 2025 Results

FARMINGDALE, N.Y., June 16, 2025 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (OTCQX: ENZB) (“Enzo” or the “Company”) today announced financial results for the fiscal third quarter ended April 30, 2025.

ANAVEX SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Anavex Life Sciences Corp. (NASDAQ: AVXL) and Encourages Long-Term Investors to Contact the Firm

PHILADELPHIA, June 16, 2025 (GLOBE NEWSWIRE) -- The law firm of Kaskela Law LLC announces that it is investigating potential breach of fiduciary duty claims concerning Anavex Life Sciences Corp. (NASDAQ: AVXL) (“Anavex”) on behalf of the company’s long-term shareholders. 

Finnish Australian Venture Agora Launches Personalized AI Doctors

Female-led startup introduces Build Your Own Doc, turning preventive wellness into a data-driven gamified experience
 Female-led startup introduces Build Your Own Doc, turning preventive wellness into a data-driven gamified experience

- A word from our sponsors -

spot_img

Follow us